Created in 2004, Nokad has developed an original and patented strategy to allow the development of screening tests for heart disease and stroke. The route is fraught with difficulties, but NOKAD has a secret: tenacity.
Diagnostics:
Nokad's objectives for arterial thrombosis risk factors
> More accurate tests for platelet activation
> Risk stratification in healthy individuals and patients
> Personalized therapy
> Prevention of first event and relapse
Clinical trials ongoing on stroke patients and healthy controls
Therapeutics:
Nokad's objectives for arterial thrombosis treatment
> Personalized antiplatelets therapy
> Reduced hemorrhagic side-effects
> Reduced relapse and death
R&D platform:
Functionnal knock-out technology
> In silico design
> Innovative in vivo target validation strategies
Copyright © 2013 Nokad Pharma. Tous droits réservés.